{"id":4917,"date":"2024-04-24T09:48:05","date_gmt":"2024-04-24T07:48:05","guid":{"rendered":"https:\/\/www-test.cross4channel.de\/?p=4917"},"modified":"2024-04-25T13:01:24","modified_gmt":"2024-04-25T11:01:24","slug":"cross4channel-relauncht-evalii-de-die-website-zur-innovativen-plattform-fuer-pharmakovigilanz-monitoring-und-social-media-moderation","status":"publish","type":"post","link":"https:\/\/www.crossinvestics.de\/en\/cross4channel-relauncht-evalii-de-die-website-zur-innovativen-plattform-fuer-pharmakovigilanz-monitoring-und-social-media-moderation\/","title":{"rendered":"Cross4Channel\u00ae relaunches evalii.de \u2013 The website for the innovative platform for pharmacovigilance monitoring and social media moderation"},"content":{"rendered":"<p>Berlin, April 22, 2024 \u2013 Cross4Channel GmbH, a company of the Crossinvestics\u00ae innovations group and a leading provider of digital solutions in the healthcare sector, is pleased to announce the relaunch of the website evalii.de. <strong>evalii\u00ae <\/strong>as a platform has been in use since 2017 and has set new standards in the field of <strong>Pharmacovigilance monitoring <\/strong>and the <strong>Social Media Moderation <\/strong>set.<\/p>\n\n\n\n<p>evalii\u00ae has been specifically developed to help pharmaceutical companies comply with legal regulations while optimizing communication with customers or those affected via digital channels. Using artificial intelligence, the system automatically classifies messages according to their relevance to pharmacovigilance and documents them within seconds. One of evalii\u00ae&#039;s highly qualified and specially trained employees then processes the data sets prepared by the system. These experts (from the fields of medicine, pharmacy, veterinary sciences and biochemistry, among others) carefully review the content and make informed decisions about how to handle the information. This process ensures that all pharmacovigilance-relevant data is not only recorded, but also evaluated and processed in accordance with regulatory requirements and taking the clinical context into account. This combination of automated detection and manual expertise enables our customers to rely on the quality and compliance of their pharmacovigilance activities.<\/p>\n\n\n\n<p>The 24\/7 monitoring of digital channels such as Facebook, Instagram, Twitter, YouTube and many others makes it possible to scan all posts and comments around the clock and document them accordingly.<\/p>\n\n\n\n<p>&quot;Our goal in developing evalii\u00ae was to create a solution that is not only efficient and compliant with data protection regulations, but also meets the regulatory requirements of pharmacovigilance monitoring. evalii\u00ae&#039;s monitoring and moderation functions also make it possible to respond to contributions in accordance with the individual specifications of pharmaceutical companies,&quot; says Andrea Kurz, pharmacist and Head of Operations at Cross4Channel GmbH.<\/p>\n\n\n\n<p>The new website provides detailed information about the system&#039;s functionalities and benefits, including continuous monitoring and reporting of social media posts, compliance with legal frameworks, and a data center that meets the ISO 27001 standard.<\/p>\n\n\n\n<p>evalii\u00ae is available in almost all languages and thus offers broad international coverage, which is particularly important for globally operating pharmaceutical companies.<\/p>\n\n\n\n<p>For more information please visit <a href=\"https:\/\/www.evalii.de\/\">evalii.de <\/a>or contact our support team at <a href=\"mailto:info@cross4channel.de\">info@cross4channel.de<\/a>.<\/p>","protected":false},"excerpt":{"rendered":"<p>Berlin, 22. April 2024 \u2013 Die Cross4Channel GmbH, ein Unternehmen der Crossinvestics\u00ae innovations group und ein f\u00fchrender Anbieter von digitalen L\u00f6sungen im Gesundheitssektor, freut sich, den Relaunch der Website evalii.de bekanntzugeben. evalii\u00ae als Plattform ist seit 2017 im Einsatz und hat neue Ma\u00dfst\u00e4be im Bereich des Pharmakovigilanz-Monitorings und der Social Media Moderation gesetzt. evalii\u00ae ist [&hellip;]<\/p>","protected":false},"author":1,"featured_media":4928,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20],"tags":[],"class_list":["post-4917","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pharmakovigilanz"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Cross4Channel\u00ae relauncht evalii.de \u2013 Die Website zur innovativen Plattform f\u00fcr Pharmakovigilanz-Monitoring und Social Media Moderation - Crossinvestics\u00ae GmbH<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.crossinvestics.de\/en\/cross4channel-relauncht-evalii-de-die-website-zur-innovativen-plattform-fuer-pharmakovigilanz-monitoring-und-social-media-moderation\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cross4Channel\u00ae relauncht evalii.de \u2013 Die Website zur innovativen Plattform f\u00fcr Pharmakovigilanz-Monitoring und Social Media Moderation - Crossinvestics\u00ae GmbH\" \/>\n<meta property=\"og:description\" content=\"Berlin, 22. April 2024 \u2013 Die Cross4Channel GmbH, ein Unternehmen der Crossinvestics\u00ae innovations group und ein f\u00fchrender Anbieter von digitalen L\u00f6sungen im Gesundheitssektor, freut sich, den Relaunch der Website evalii.de bekanntzugeben. evalii\u00ae als Plattform ist seit 2017 im Einsatz und hat neue Ma\u00dfst\u00e4be im Bereich des Pharmakovigilanz-Monitorings und der Social Media Moderation gesetzt. evalii\u00ae ist [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.crossinvestics.de\/en\/cross4channel-relauncht-evalii-de-die-website-zur-innovativen-plattform-fuer-pharmakovigilanz-monitoring-und-social-media-moderation\/\" \/>\n<meta property=\"og:site_name\" content=\"Crossinvestics\u00ae GmbH\" \/>\n<meta property=\"article:published_time\" content=\"2024-04-24T07:48:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-04-25T11:01:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.crossinvestics.de\/wp-content\/uploads\/2024\/04\/eva-logo.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"512\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"c4cadmin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"c4cadmin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.crossinvestics.de\/cross4channel-relauncht-evalii-de-die-website-zur-innovativen-plattform-fuer-pharmakovigilanz-monitoring-und-social-media-moderation\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.crossinvestics.de\/cross4channel-relauncht-evalii-de-die-website-zur-innovativen-plattform-fuer-pharmakovigilanz-monitoring-und-social-media-moderation\/\"},\"author\":{\"name\":\"c4cadmin\",\"@id\":\"https:\/\/www.crossinvestics.de\/#\/schema\/person\/068081ac8e92537995322ee2b949bce4\"},\"headline\":\"Cross4Channel\u00ae relauncht evalii.de \u2013 Die Website zur innovativen Plattform f\u00fcr Pharmakovigilanz-Monitoring und Social Media Moderation\",\"datePublished\":\"2024-04-24T07:48:05+00:00\",\"dateModified\":\"2024-04-25T11:01:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.crossinvestics.de\/cross4channel-relauncht-evalii-de-die-website-zur-innovativen-plattform-fuer-pharmakovigilanz-monitoring-und-social-media-moderation\/\"},\"wordCount\":419,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.crossinvestics.de\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.crossinvestics.de\/cross4channel-relauncht-evalii-de-die-website-zur-innovativen-plattform-fuer-pharmakovigilanz-monitoring-und-social-media-moderation\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.crossinvestics.de\/wp-content\/uploads\/2024\/04\/eva-logo.png\",\"articleSection\":[\"Pharmakovigilanz\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.crossinvestics.de\/cross4channel-relauncht-evalii-de-die-website-zur-innovativen-plattform-fuer-pharmakovigilanz-monitoring-und-social-media-moderation\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.crossinvestics.de\/cross4channel-relauncht-evalii-de-die-website-zur-innovativen-plattform-fuer-pharmakovigilanz-monitoring-und-social-media-moderation\/\",\"url\":\"https:\/\/www.crossinvestics.de\/cross4channel-relauncht-evalii-de-die-website-zur-innovativen-plattform-fuer-pharmakovigilanz-monitoring-und-social-media-moderation\/\",\"name\":\"Cross4Channel\u00ae relauncht evalii.de \u2013 Die Website zur innovativen Plattform f\u00fcr Pharmakovigilanz-Monitoring und Social Media Moderation - Crossinvestics\u00ae GmbH\",\"isPartOf\":{\"@id\":\"https:\/\/www.crossinvestics.de\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.crossinvestics.de\/cross4channel-relauncht-evalii-de-die-website-zur-innovativen-plattform-fuer-pharmakovigilanz-monitoring-und-social-media-moderation\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.crossinvestics.de\/cross4channel-relauncht-evalii-de-die-website-zur-innovativen-plattform-fuer-pharmakovigilanz-monitoring-und-social-media-moderation\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.crossinvestics.de\/wp-content\/uploads\/2024\/04\/eva-logo.png\",\"datePublished\":\"2024-04-24T07:48:05+00:00\",\"dateModified\":\"2024-04-25T11:01:24+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.crossinvestics.de\/cross4channel-relauncht-evalii-de-die-website-zur-innovativen-plattform-fuer-pharmakovigilanz-monitoring-und-social-media-moderation\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.crossinvestics.de\/cross4channel-relauncht-evalii-de-die-website-zur-innovativen-plattform-fuer-pharmakovigilanz-monitoring-und-social-media-moderation\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.crossinvestics.de\/cross4channel-relauncht-evalii-de-die-website-zur-innovativen-plattform-fuer-pharmakovigilanz-monitoring-und-social-media-moderation\/#primaryimage\",\"url\":\"https:\/\/www.crossinvestics.de\/wp-content\/uploads\/2024\/04\/eva-logo.png\",\"contentUrl\":\"https:\/\/www.crossinvestics.de\/wp-content\/uploads\/2024\/04\/eva-logo.png\",\"width\":1024,\"height\":512},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.crossinvestics.de\/cross4channel-relauncht-evalii-de-die-website-zur-innovativen-plattform-fuer-pharmakovigilanz-monitoring-und-social-media-moderation\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\/\/www.crossinvestics.de\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cross4Channel\u00ae relauncht evalii.de \u2013 Die Website zur innovativen Plattform f\u00fcr Pharmakovigilanz-Monitoring und Social Media Moderation\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.crossinvestics.de\/#website\",\"url\":\"https:\/\/www.crossinvestics.de\/\",\"name\":\"Crossinvestics\u00ae GmbH\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.crossinvestics.de\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.crossinvestics.de\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.crossinvestics.de\/#organization\",\"name\":\"Crossinvestics\u00ae GmbH\",\"url\":\"https:\/\/www.crossinvestics.de\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.crossinvestics.de\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.crossinvestics.de\/wp-content\/uploads\/2024\/05\/Group-partial-White@3x-noborder-header.png\",\"contentUrl\":\"https:\/\/www.crossinvestics.de\/wp-content\/uploads\/2024\/05\/Group-partial-White@3x-noborder-header.png\",\"width\":250,\"height\":61,\"caption\":\"Crossinvestics\u00ae GmbH\"},\"image\":{\"@id\":\"https:\/\/www.crossinvestics.de\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.crossinvestics.de\/#\/schema\/person\/068081ac8e92537995322ee2b949bce4\",\"name\":\"c4cadmin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.crossinvestics.de\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/f17ab52e65b8e331831db9800771b3e38da775094aea5a14be76ab1dbcc595ca?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/f17ab52e65b8e331831db9800771b3e38da775094aea5a14be76ab1dbcc595ca?s=96&d=mm&r=g\",\"caption\":\"c4cadmin\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cross4Channel\u00ae relauncht evalii.de \u2013 Die Website zur innovativen Plattform f\u00fcr Pharmakovigilanz-Monitoring und Social Media Moderation - Crossinvestics\u00ae GmbH","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.crossinvestics.de\/en\/cross4channel-relauncht-evalii-de-die-website-zur-innovativen-plattform-fuer-pharmakovigilanz-monitoring-und-social-media-moderation\/","og_locale":"en_US","og_type":"article","og_title":"Cross4Channel\u00ae relauncht evalii.de \u2013 Die Website zur innovativen Plattform f\u00fcr Pharmakovigilanz-Monitoring und Social Media Moderation - Crossinvestics\u00ae GmbH","og_description":"Berlin, 22. April 2024 \u2013 Die Cross4Channel GmbH, ein Unternehmen der Crossinvestics\u00ae innovations group und ein f\u00fchrender Anbieter von digitalen L\u00f6sungen im Gesundheitssektor, freut sich, den Relaunch der Website evalii.de bekanntzugeben. evalii\u00ae als Plattform ist seit 2017 im Einsatz und hat neue Ma\u00dfst\u00e4be im Bereich des Pharmakovigilanz-Monitorings und der Social Media Moderation gesetzt. evalii\u00ae ist [&hellip;]","og_url":"https:\/\/www.crossinvestics.de\/en\/cross4channel-relauncht-evalii-de-die-website-zur-innovativen-plattform-fuer-pharmakovigilanz-monitoring-und-social-media-moderation\/","og_site_name":"Crossinvestics\u00ae GmbH","article_published_time":"2024-04-24T07:48:05+00:00","article_modified_time":"2024-04-25T11:01:24+00:00","og_image":[{"width":1024,"height":512,"url":"https:\/\/www.crossinvestics.de\/wp-content\/uploads\/2024\/04\/eva-logo.png","type":"image\/png"}],"author":"c4cadmin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"c4cadmin","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.crossinvestics.de\/cross4channel-relauncht-evalii-de-die-website-zur-innovativen-plattform-fuer-pharmakovigilanz-monitoring-und-social-media-moderation\/#article","isPartOf":{"@id":"https:\/\/www.crossinvestics.de\/cross4channel-relauncht-evalii-de-die-website-zur-innovativen-plattform-fuer-pharmakovigilanz-monitoring-und-social-media-moderation\/"},"author":{"name":"c4cadmin","@id":"https:\/\/www.crossinvestics.de\/#\/schema\/person\/068081ac8e92537995322ee2b949bce4"},"headline":"Cross4Channel\u00ae relauncht evalii.de \u2013 Die Website zur innovativen Plattform f\u00fcr Pharmakovigilanz-Monitoring und Social Media Moderation","datePublished":"2024-04-24T07:48:05+00:00","dateModified":"2024-04-25T11:01:24+00:00","mainEntityOfPage":{"@id":"https:\/\/www.crossinvestics.de\/cross4channel-relauncht-evalii-de-die-website-zur-innovativen-plattform-fuer-pharmakovigilanz-monitoring-und-social-media-moderation\/"},"wordCount":419,"commentCount":0,"publisher":{"@id":"https:\/\/www.crossinvestics.de\/#organization"},"image":{"@id":"https:\/\/www.crossinvestics.de\/cross4channel-relauncht-evalii-de-die-website-zur-innovativen-plattform-fuer-pharmakovigilanz-monitoring-und-social-media-moderation\/#primaryimage"},"thumbnailUrl":"https:\/\/www.crossinvestics.de\/wp-content\/uploads\/2024\/04\/eva-logo.png","articleSection":["Pharmakovigilanz"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.crossinvestics.de\/cross4channel-relauncht-evalii-de-die-website-zur-innovativen-plattform-fuer-pharmakovigilanz-monitoring-und-social-media-moderation\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.crossinvestics.de\/cross4channel-relauncht-evalii-de-die-website-zur-innovativen-plattform-fuer-pharmakovigilanz-monitoring-und-social-media-moderation\/","url":"https:\/\/www.crossinvestics.de\/cross4channel-relauncht-evalii-de-die-website-zur-innovativen-plattform-fuer-pharmakovigilanz-monitoring-und-social-media-moderation\/","name":"Cross4Channel\u00ae relauncht evalii.de \u2013 Die Website zur innovativen Plattform f\u00fcr Pharmakovigilanz-Monitoring und Social Media Moderation - Crossinvestics\u00ae GmbH","isPartOf":{"@id":"https:\/\/www.crossinvestics.de\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.crossinvestics.de\/cross4channel-relauncht-evalii-de-die-website-zur-innovativen-plattform-fuer-pharmakovigilanz-monitoring-und-social-media-moderation\/#primaryimage"},"image":{"@id":"https:\/\/www.crossinvestics.de\/cross4channel-relauncht-evalii-de-die-website-zur-innovativen-plattform-fuer-pharmakovigilanz-monitoring-und-social-media-moderation\/#primaryimage"},"thumbnailUrl":"https:\/\/www.crossinvestics.de\/wp-content\/uploads\/2024\/04\/eva-logo.png","datePublished":"2024-04-24T07:48:05+00:00","dateModified":"2024-04-25T11:01:24+00:00","breadcrumb":{"@id":"https:\/\/www.crossinvestics.de\/cross4channel-relauncht-evalii-de-die-website-zur-innovativen-plattform-fuer-pharmakovigilanz-monitoring-und-social-media-moderation\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.crossinvestics.de\/cross4channel-relauncht-evalii-de-die-website-zur-innovativen-plattform-fuer-pharmakovigilanz-monitoring-und-social-media-moderation\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.crossinvestics.de\/cross4channel-relauncht-evalii-de-die-website-zur-innovativen-plattform-fuer-pharmakovigilanz-monitoring-und-social-media-moderation\/#primaryimage","url":"https:\/\/www.crossinvestics.de\/wp-content\/uploads\/2024\/04\/eva-logo.png","contentUrl":"https:\/\/www.crossinvestics.de\/wp-content\/uploads\/2024\/04\/eva-logo.png","width":1024,"height":512},{"@type":"BreadcrumbList","@id":"https:\/\/www.crossinvestics.de\/cross4channel-relauncht-evalii-de-die-website-zur-innovativen-plattform-fuer-pharmakovigilanz-monitoring-und-social-media-moderation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.crossinvestics.de\/"},{"@type":"ListItem","position":2,"name":"Cross4Channel\u00ae relauncht evalii.de \u2013 Die Website zur innovativen Plattform f\u00fcr Pharmakovigilanz-Monitoring und Social Media Moderation"}]},{"@type":"WebSite","@id":"https:\/\/www.crossinvestics.de\/#website","url":"https:\/\/www.crossinvestics.de\/","name":"Crossinvestics\u00ae GmbH","description":"","publisher":{"@id":"https:\/\/www.crossinvestics.de\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.crossinvestics.de\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.crossinvestics.de\/#organization","name":"Crossinvestics\u00ae GmbH","url":"https:\/\/www.crossinvestics.de\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.crossinvestics.de\/#\/schema\/logo\/image\/","url":"https:\/\/www.crossinvestics.de\/wp-content\/uploads\/2024\/05\/Group-partial-White@3x-noborder-header.png","contentUrl":"https:\/\/www.crossinvestics.de\/wp-content\/uploads\/2024\/05\/Group-partial-White@3x-noborder-header.png","width":250,"height":61,"caption":"Crossinvestics\u00ae GmbH"},"image":{"@id":"https:\/\/www.crossinvestics.de\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.crossinvestics.de\/#\/schema\/person\/068081ac8e92537995322ee2b949bce4","name":"c4cadmin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.crossinvestics.de\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/f17ab52e65b8e331831db9800771b3e38da775094aea5a14be76ab1dbcc595ca?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f17ab52e65b8e331831db9800771b3e38da775094aea5a14be76ab1dbcc595ca?s=96&d=mm&r=g","caption":"c4cadmin"}}]}},"_links":{"self":[{"href":"https:\/\/www.crossinvestics.de\/en\/wp-json\/wp\/v2\/posts\/4917","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.crossinvestics.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.crossinvestics.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.crossinvestics.de\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.crossinvestics.de\/en\/wp-json\/wp\/v2\/comments?post=4917"}],"version-history":[{"count":3,"href":"https:\/\/www.crossinvestics.de\/en\/wp-json\/wp\/v2\/posts\/4917\/revisions"}],"predecessor-version":[{"id":5250,"href":"https:\/\/www.crossinvestics.de\/en\/wp-json\/wp\/v2\/posts\/4917\/revisions\/5250"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.crossinvestics.de\/en\/wp-json\/wp\/v2\/media\/4928"}],"wp:attachment":[{"href":"https:\/\/www.crossinvestics.de\/en\/wp-json\/wp\/v2\/media?parent=4917"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.crossinvestics.de\/en\/wp-json\/wp\/v2\/categories?post=4917"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.crossinvestics.de\/en\/wp-json\/wp\/v2\/tags?post=4917"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}